Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002440.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -14.17 3.64 4.24
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 49.48 -12.92 -25.57
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.36 8.37 8.02
Cash 18.60 1.88 1.59
Capex -4121.87 -0.04 < 0.005
Free Cash Flow 147.62 0.03 0.01
Revenue -5.16 1.11 1.17
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 35.35 0.17 0.13
Operating Margin 20.66 0.03 -0.03
ROA -97.68 < 0.005 < 0.005
ROE -97.67 < 0.005 < 0.005
ROIC -74.80 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002440.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002440.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002440.SZ is permitted for members.